Clinical Scorecard: An Exploratory Prospective Cohort Study on a Tailored Oral Glucose Loading Protocol for 18F-FDG PET Myocardial Metabolic Imaging in Diabetic Patients with Coronary Artery Disease

At a Glance

Key Highlights

• 179 CAD patients with DM were enrolled in the study.
• FDG image quality was excellent in 57.5% of patients.
• Image quality varied significantly with blood glucose levels at FDG injection.
• No severe adverse reactions were reported during the study.
• The tailored glucose loading protocol is feasible for clinical application.

Guideline-Based Recommendations

Diagnosis

• Utilize 18F-FDG PET combined with myocardial perfusion imaging for assessing myocardial viability.

Management

• Implement a tailored oral glucose loading and insulin administration protocol prior to imaging.

Monitoring & Follow-up

• Assess blood glucose levels before FDG injection to optimize image quality.

Risks

• Monitor for potential adverse reactions during metabolic preparation.

Patient & Prescribing Data

Patients with CAD and DM undergoing myocardial viability assessment.

Individualized glucose dosing based on baseline blood glucose improves imaging outcomes.

Clinical Best Practices

• Adhere to fasting protocols prior to PET imaging.
• Evaluate myocardial viability using both MMI and MPI for accurate diagnosis.

Related Resources & Content

• American Society of Nuclear Cardiology Guidelines
• American Diabetes Association Guidelines